SENNA-PLUS
NDC 57896-555, Sennosides and Docusate Sodium, tablet, from Geri-Care Pharmaceutical Corp.
- Product NDC
- 57896-555
- Status
- Listed
- Labeler
- Geri-Care Pharmaceutical Corp
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- 505G(a)(3)
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/57896-555 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SENNOSIDES8.6 mg/1
- DOCUSATE SODIUM50 mg/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 57896-555-01 | 57896055501 | 100 TABLET in 1 BOTTLE (57896-555-01) |
| 57896-555-06 | 57896055506 | 60 TABLET in 1 BOTTLE (57896-555-06) |
| 57896-555-10 | 57896055510 | 1000 TABLET in 1 BOTTLE (57896-555-10) |
| 57896-555-20 | 57896055520 | 200 TABLET in 1 BOTTLE (57896-555-20) |
Linked data
RxNorm, label and prices
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 57896-555 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/57896-555 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 57896-555. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.